MX2009008118A - Polipeptido e2 del virus del papiloma usado para vacunacion. - Google Patents
Polipeptido e2 del virus del papiloma usado para vacunacion.Info
- Publication number
- MX2009008118A MX2009008118A MX2009008118A MX2009008118A MX2009008118A MX 2009008118 A MX2009008118 A MX 2009008118A MX 2009008118 A MX2009008118 A MX 2009008118A MX 2009008118 A MX2009008118 A MX 2009008118A MX 2009008118 A MX2009008118 A MX 2009008118A
- Authority
- MX
- Mexico
- Prior art keywords
- papillomavirus
- polypeptide
- nucleotide
- vector
- vaccination
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07360004 | 2007-01-30 | ||
EP07360018 | 2007-05-15 | ||
PCT/EP2008/051032 WO2008092854A2 (en) | 2007-01-30 | 2008-01-29 | Papillomavirus e2 polypeptide used for vaccination |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009008118A true MX2009008118A (es) | 2009-10-13 |
Family
ID=39399907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008118A MX2009008118A (es) | 2007-01-30 | 2008-01-29 | Polipeptido e2 del virus del papiloma usado para vacunacion. |
Country Status (20)
Country | Link |
---|---|
US (1) | US8420103B2 (de) |
EP (2) | EP2118292B1 (de) |
JP (1) | JP5474567B2 (de) |
KR (1) | KR101636575B1 (de) |
CN (1) | CN101617052A (de) |
AR (1) | AR065076A1 (de) |
AT (1) | ATE518958T1 (de) |
AU (1) | AU2008209759B2 (de) |
BR (1) | BRPI0806350A2 (de) |
CA (1) | CA2675355C (de) |
CL (1) | CL2008000249A1 (de) |
DK (1) | DK2118292T3 (de) |
IL (2) | IL199939A (de) |
MX (1) | MX2009008118A (de) |
PE (1) | PE20081723A1 (de) |
PL (1) | PL2118292T3 (de) |
RU (2) | RU2482189C2 (de) |
TW (1) | TW200840869A (de) |
WO (1) | WO2008092854A2 (de) |
ZA (1) | ZA200904932B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5474767B2 (ja) * | 2007-05-15 | 2014-04-16 | トランジェーヌ、ソシエテ、アノニム | 多重遺伝子発現のためのベクター |
TW200844230A (en) | 2007-05-15 | 2008-11-16 | Transgene Sa | Signaling peptides |
WO2014009433A1 (en) | 2012-07-10 | 2014-01-16 | Transgene Sa | Mycobacterium resuscitation promoting factor for use as adjuvant |
WO2015149051A1 (en) * | 2014-03-28 | 2015-10-01 | The Johns Hopkins University | Treatment regimen using cancer vaccines and local adjuvants and their use |
CN107075521B (zh) * | 2014-11-04 | 2021-06-08 | 扬森疫苗与预防公司 | 治疗性hpv16疫苗 |
WO2017210649A1 (en) * | 2016-06-03 | 2017-12-07 | Etubics Corporation | Compositions and methods for the treatment of human papillomavirus (hpv)-associated diseases |
EP3518966A1 (de) * | 2016-09-29 | 2019-08-07 | GlaxoSmithKline Biologicals S.A. | Zusammensetzungen und verfahren zur behandlung von persistenten hpv-infektionen |
CN111065406A (zh) | 2017-06-21 | 2020-04-24 | 特兰斯吉恩股份有限公司 | 个性化疫苗 |
EP3461497A1 (de) | 2017-09-27 | 2019-04-03 | GlaxoSmithKline Biologicals S.A. | Virale antigene |
US11012555B2 (en) | 2017-11-20 | 2021-05-18 | International Business Machines Corporation | Non-verbal sensitive data authentication |
KR102222582B1 (ko) * | 2018-02-02 | 2021-03-04 | 주식회사 에스엘백시젠 | 신규 다가 hpv 백신 조성물 |
JP2021516957A (ja) | 2018-03-07 | 2021-07-15 | トランジェーヌTransgene | パラポックスウイルスベクター |
CN116200416B (zh) * | 2023-02-15 | 2024-03-12 | 北京康乐卫士生物技术股份有限公司 | 一种基于Tac启动子的质粒表达载体构建及其用途 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4711955A (en) | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
CA1223831A (en) | 1982-06-23 | 1987-07-07 | Dean Engelhardt | Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
FR2643817B1 (fr) | 1989-03-06 | 1993-12-17 | Transgene Sa | Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus |
DE3642912A1 (de) | 1986-12-16 | 1988-06-30 | Leybold Ag | Messeinrichtung fuer paramagnetische messgeraete mit einer messkammer |
FR2632863B2 (fr) | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
US5100587A (en) | 1989-11-13 | 1992-03-31 | The United States Of America As Represented By The Department Of Energy | Solid-state radioluminescent zeolite-containing composition and light sources |
US5756102A (en) | 1990-11-20 | 1998-05-26 | Virogenetics Corporation | Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
KR100242671B1 (ko) | 1991-03-07 | 2000-03-02 | 고돈 에릭 | 유전학적으로 처리한 백신 균주 |
GB9105383D0 (en) * | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
US5179993A (en) | 1991-03-26 | 1993-01-19 | Hughes Aircraft Company | Method of fabricating anisometric metal needles and birefringent suspension thereof in dielectric fluid |
DE4123760C2 (de) | 1991-07-18 | 2000-01-20 | Dade Behring Marburg Gmbh | Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2 |
US6013638A (en) | 1991-10-02 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung |
GB9223084D0 (en) | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
US5674703A (en) * | 1992-12-02 | 1997-10-07 | Woo; Savio L. C. | Episomal vector systems and related methods |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
US6133028A (en) | 1993-05-28 | 2000-10-17 | Transgene S.A. | Defective adenoviruses and corresponding complementation lines |
US5698443A (en) | 1995-06-27 | 1997-12-16 | Calydon, Inc. | Tissue specific viral vectors |
MXPA96005662A (es) * | 1994-05-16 | 2004-08-19 | Merck & Co Inc | Vacunas de papilomavirus. |
US5525711A (en) | 1994-05-18 | 1996-06-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Pteridine nucleotide analogs as fluorescent DNA probes |
US6638762B1 (en) | 1994-11-28 | 2003-10-28 | Genetic Therapy, Inc. | Tissue-vectors specific replication and gene expression |
US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
FR2727689A1 (fr) | 1994-12-01 | 1996-06-07 | Transgene Sa | Nouveau procede de preparation d'un vecteur viral |
US5837520A (en) | 1995-03-07 | 1998-11-17 | Canji, Inc. | Method of purification of viral vectors |
FR2749323B1 (fr) * | 1996-06-04 | 1998-07-10 | Pasteur Merieux Serums Vacc | Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique |
IL127692A0 (en) | 1996-07-01 | 1999-10-28 | Rhone Poulenc Rorer Sa | Method for producing recombinant adenovirus |
KR100503701B1 (ko) | 1996-11-20 | 2005-07-26 | 인트로겐 테라페티스, 인코퍼레이티드 | 아데노바이러스 벡터를 생산하고 정제하는 개선된 방법 |
ATE477320T1 (de) | 1996-12-13 | 2010-08-15 | Schering Corp | Methoden zur virus-reinigung |
WO1998056415A1 (en) | 1997-06-11 | 1998-12-17 | Aquila Biopharmaceuticals, Inc. | Purified saponins as oral adjuvants |
FR2766091A1 (fr) | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
WO1999014377A2 (en) | 1997-09-16 | 1999-03-25 | Innogenetics N.V. | Detection and identification of human papillomavirus by pcr and type-specific reverse hybridization |
WO2000046355A2 (en) | 1999-02-04 | 2000-08-10 | Geron Corporation | Telomerase reverse transcriptase transcriptional regulatory sequences |
FR2774699B1 (fr) * | 1997-11-17 | 2003-10-03 | Rhone Poulenc Rorer Sa | Methode de reduction des evenements de recombinaison homologue |
FR2777570A1 (fr) | 1998-04-17 | 1999-10-22 | Transgene Sa | Mutant ayant une activite phosphoribosyl transferase |
JP3864610B2 (ja) | 1998-05-21 | 2007-01-10 | 旭硝子株式会社 | 水分散型撥水撥油剤組成物およびその製造方法 |
US6900049B2 (en) | 1998-09-10 | 2005-05-31 | Cell Genesys, Inc. | Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
US20020037274A1 (en) | 1998-10-26 | 2002-03-28 | Angelica Williams | Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
US6582693B2 (en) * | 1998-11-30 | 2003-06-24 | Lemery, S.A. De C.V. | Recombinant MVA virus expressing the E2 gene of Bovine papillomavirus and its use in the therapy of tumors generated by papillomaviruses |
FR2787465A1 (fr) | 1998-12-21 | 2000-06-23 | Transgene Sa | Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes |
CZ20012428A3 (cs) | 1998-12-31 | 2001-11-14 | Aventis Pharma S. A. | Způsob separace virových částic |
DE60029195T2 (de) | 1999-02-22 | 2007-06-28 | Transgene S.A. | Verfahren zur Gewinnung von purifizierter Virenzusammensetzung |
US6492169B1 (en) | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
WO2001014416A2 (en) | 1999-08-25 | 2001-03-01 | Merck & Co., Inc. | Synthetic papillomavirus genes optimized for expression in human cells |
EP1230378B1 (de) | 1999-11-15 | 2007-06-06 | Onyx Pharmaceuticals, Inc. | Ein oncolytisches adenovirus |
CA2341356C (en) | 2000-04-14 | 2011-10-11 | Transgene S.A. | Poxvirus with targeted infection specificity |
US20020029498A1 (en) | 2000-07-03 | 2002-03-14 | Howard Harrison | Rapid cool iron and related iron improvements |
WO2002008435A1 (en) | 2000-07-21 | 2002-01-31 | Glaxo Group Limited | Codon-optimized papilloma virus sequences |
JP4080423B2 (ja) | 2001-05-30 | 2008-04-23 | トランジェーヌ、ソシエテ、アノニム | アデノウイルスタンパク質ix、ならびにキャプシドアセンブリー、転写活性および核再組織化に関与するそのドメイン |
CA2457890A1 (en) | 2001-08-23 | 2003-03-06 | Merck & Co., Inc. | Vaccine using papillomavirus e proteins delivered by viral vector |
JP4895505B2 (ja) * | 2002-05-16 | 2012-03-14 | バヴァリアン・ノルディック・アクティーゼルスカブ | 変異ワクシニアウイルスアンカラ(mva)ゲノム中の挿入部位としての遺伝子間領域 |
GB0222953D0 (en) * | 2002-10-03 | 2002-11-13 | Glaxo Group Ltd | Novel Compounds |
US20090028874A1 (en) * | 2003-12-24 | 2009-01-29 | Leiden University Medical Center | Synthetic Protein as Tumor-Specific Vaccine |
US20070014810A1 (en) | 2003-12-31 | 2007-01-18 | Denise Baker | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
-
2008
- 2008-01-29 CN CN200880003650A patent/CN101617052A/zh active Pending
- 2008-01-29 JP JP2009547667A patent/JP5474567B2/ja not_active Expired - Fee Related
- 2008-01-29 KR KR1020097016704A patent/KR101636575B1/ko active IP Right Grant
- 2008-01-29 BR BRPI0806350-8A patent/BRPI0806350A2/pt not_active Application Discontinuation
- 2008-01-29 MX MX2009008118A patent/MX2009008118A/es active IP Right Grant
- 2008-01-29 PE PE2008000212A patent/PE20081723A1/es not_active Application Discontinuation
- 2008-01-29 WO PCT/EP2008/051032 patent/WO2008092854A2/en active Application Filing
- 2008-01-29 AR ARP080100357A patent/AR065076A1/es not_active Application Discontinuation
- 2008-01-29 TW TW097103230A patent/TW200840869A/zh unknown
- 2008-01-29 DK DK08708349.9T patent/DK2118292T3/da active
- 2008-01-29 EP EP08708349A patent/EP2118292B1/de not_active Not-in-force
- 2008-01-29 AU AU2008209759A patent/AU2008209759B2/en not_active Ceased
- 2008-01-29 CL CL200800249A patent/CL2008000249A1/es unknown
- 2008-01-29 AT AT08708349T patent/ATE518958T1/de not_active IP Right Cessation
- 2008-01-29 PL PL08708349T patent/PL2118292T3/pl unknown
- 2008-01-29 CA CA2675355A patent/CA2675355C/en not_active Expired - Fee Related
- 2008-01-29 US US12/449,197 patent/US8420103B2/en not_active Expired - Fee Related
- 2008-01-29 EP EP11175811A patent/EP2390340A3/de not_active Withdrawn
- 2008-01-29 RU RU2009130791/10A patent/RU2482189C2/ru not_active IP Right Cessation
-
2009
- 2009-01-01 ZA ZA200904932A patent/ZA200904932B/xx unknown
- 2009-07-19 IL IL199939A patent/IL199939A/en active IP Right Grant
-
2011
- 2011-10-06 IL IL215599A patent/IL215599A/en not_active IP Right Cessation
-
2013
- 2013-01-17 RU RU2013102035/10A patent/RU2013102035A/ru unknown
Also Published As
Publication number | Publication date |
---|---|
JP5474567B2 (ja) | 2014-04-16 |
US20100143408A1 (en) | 2010-06-10 |
RU2013102035A (ru) | 2014-07-27 |
IL215599A (en) | 2014-11-30 |
CN101617052A (zh) | 2009-12-30 |
CA2675355A1 (en) | 2008-08-07 |
ZA200904932B (en) | 2010-04-28 |
CL2008000249A1 (es) | 2008-05-30 |
AU2008209759A1 (en) | 2008-08-07 |
EP2118292A2 (de) | 2009-11-18 |
US8420103B2 (en) | 2013-04-16 |
WO2008092854A3 (en) | 2008-10-30 |
RU2009130791A (ru) | 2011-03-10 |
EP2390340A2 (de) | 2011-11-30 |
EP2390340A3 (de) | 2012-02-22 |
PL2118292T3 (pl) | 2011-12-30 |
DK2118292T3 (da) | 2011-10-24 |
CA2675355C (en) | 2015-04-28 |
IL199939A (en) | 2013-02-28 |
KR20090129399A (ko) | 2009-12-16 |
AR065076A1 (es) | 2009-05-13 |
JP2010516287A (ja) | 2010-05-20 |
BRPI0806350A2 (pt) | 2011-09-06 |
IL215599A0 (en) | 2011-11-30 |
IL199939A0 (en) | 2010-04-15 |
KR101636575B1 (ko) | 2016-07-05 |
AU2008209759B2 (en) | 2013-03-21 |
TW200840869A (en) | 2008-10-16 |
WO2008092854A2 (en) | 2008-08-07 |
RU2482189C2 (ru) | 2013-05-20 |
PE20081723A1 (es) | 2008-12-14 |
EP2118292B1 (de) | 2011-08-03 |
ATE518958T1 (de) | 2011-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009008118A (es) | Polipeptido e2 del virus del papiloma usado para vacunacion. | |
MX2020000221A (es) | Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas. | |
BRPI0922867B8 (pt) | glicoproteina de fusão (f) de vírus sincicial respiratório (rsv), ácido nucleico isolado, célula hospedeira, composição de vacina e micela purificada | |
EP3452493A1 (de) | Nukleinsäuremoleküle und verwendungen davon | |
MX2009006760A (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedades meningococicas. | |
WO2013039861A3 (en) | Engineered nucleic acids and methods of use thereof | |
MX349481B (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. | |
NZ602471A (en) | Antagonists of activin-actriia and uses for increasing red blood cell levels | |
MXPA05011110A (es) | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos. | |
EA201692359A1 (ru) | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса | |
BR112014015016A8 (pt) | Proteína homodimérica de duas cadeias de aminoácidos idênticas, cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica, célula hospedeira, método de preparação de uma proteína homodimérica, método para preparação de uma vacina, vacina e método de tratamento ou prevenção | |
NZ595063A (en) | Polypeptides from neisseria meningitidis | |
MX2009002816A (es) | Proteinas de fusion de albumina. | |
WO2006120230A3 (en) | Host cell specific binding molecules capable of neutralizing viruses and uses thereof | |
EP2527445A3 (de) | Behandlung und Prävention von Grippe | |
RS20080174A (en) | Canine influenza virus and related compositions and methods of use | |
AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
WO2010060967A3 (en) | Compositions and methods for treating retrovirus infections | |
BR112014017242A2 (pt) | vlps contendo hpv l2 imunogênico e composições e métodos relacionados | |
MX2011008763A (es) | Peptidos foxm1 y vacunas que contienen los mismos. | |
EP4269438A3 (de) | Onkolytisches virus und verfahren | |
US10548946B2 (en) | Therapeutic compositions for neutralizing type I interferons, and methods of use | |
MX2022016287A (es) | Secuencias de acidos nucleicos y de aminoacidos de adenovirus de gorila, vectores que contienen las mismas y usos de las mismas. | |
JP2011523642A5 (de) | ||
WO2009037183A3 (de) | Nukleinsäurehaltige kosmetische und/oder pharmazeutische zubereitung zur induktion antimikrobieller peptide in epithelialen deckgeweben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |